View Author
patient treatment disease creatine activity study glucosidase blood enzyme month pompe disease effect cobalamin defect muscle metab department pompe rotterdam onset brain blood spots pediatrics level lysosomal diagnosis assay netherland 4 patients university hospital symptom children methylmalonic rhaglu analysis ammonia mutation cobalamin responsiveness outcome screening therapy control storage glycine protein erasmu aciduria deficiency genet score survival hyperinsulinism table crtr defect mut 0 patients rabbit synthesis glycogen mmauria method responsiveness metabolism erasmus rotterdam glutamine result glucosidase activity transporter 40 mg /kg blood ammonia levels concentration measurement enzyme replacement therapy glutamate function rabbit milk birth decade syndrome creatine synthesis hyperammonemia
6 Most Recent Publications
|
Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect
(Article)
van de Kamp, J.M. Pouwels, P.J.W. Salomons, G.S. Mancini, G.M.S. Aarsen, F.K. ten Hoopen, L.W. Knol, D.L. Klerk, J.B. de Coo, I.F.M. de Huijmans, J.G.M. Jakobs, C. Knaap, M.S. van der |
2011-05-10
|
|
Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots
(Article)
Oemardien, L.F. Boer, A.M. Ruijter, G.J.G. Ploeg, A.T. van der Klerk, J.B. de Reuser, A.J.J. Verheijen, F.W. |
2011-01-01
|
|
Erratum: Prediction of outcome in isolated methylmalonic acidurias: Combined use of clinical and biochemical parameters (J Inherit Metab Dis (2009) (DOI 10.1007/s10545-009-1189-6))
(Article)
Hörster, F. Garbade, S.F. Gökcay, G. Guffon, N. Maier, E.M. Morava, E. Walter, J.H. Schwahn, B. Wijburg, F.A. Lindner, M. Grünewald, S. Baumgartner, M.R. Zwickler, T. Kölker, S. Aydin, H.I. Bodamer, O.A. Burlina, A.B. Das, A. Klerk, J.B. de Dionisi-Vici, C. Geb, S. |
2009-12-01
|
|
Prediction of outcome in isolated methylmalonic acidurias: Combined use of clinical and biochemical parameters
(Article)
Hörster, F. Garbade, S.F. Dionisi-Vici, C. Geb, S. Gökcay, G. Guffon, N. Maier, E.M. Morava, E. Walter, J.H. Schwahn, B. Wijburg, F.A. Grünewald, S. Zwickler, T. Baumgartner, M.R. Lindner, M. Kölker, S. Aydin, H.I. Bodamer, O.A. Burlina, A.B. Das, A. Klerk, J.B. de |
2009-07-30
|
|
Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk
(Article)
Hout, J.M.P. van den Sibbles, B. Corven, E.J. van Hirtum, H. van Kamphoven, J.H.J. Ploeg, A.T. van der Hove, J. van Arts, W.F.M. Doorn, P.A. van Klerk, J.B. de Loonen, M.C.B. Vulto, A.G. Brakenhoff, J.P. Kroos, M.A. Hop, W.C.J. Winkel, L.P.F. Jong, G. de Cromme-Dijkhuis, A.H. Weisglas-Kuperus, N. Reuser, A.J.J. Boer, M. Smeitink, J.A. Diggelen, O.P. van Voort, E. van der |
2004-01-01
|
|
Functional hyperactivity of hepatic glutamate dehydrogenase as a cause of the hyperinsulinism/hyperammonemia syndrome: effect of treatment
(Article)
Huijmans, J.G.M. Duran, M. Klerk, J.B. de Rovers, M.J. Scholte, H.R. |
2000-01-01
|